Literature DB >> 12204224

Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells.

James G Beeson1, Stephen J Rogerson, Graham V Brown.   

Abstract

A feature of infection with Plasmodium falciparum is the ability of parasite-infected erythrocytes to adhere to vascular endothelial cells and accumulate in vital organs, associated with severe clinical disease. Hyaluronic acid was recently identified as a receptor for adhesion and has been implicated in mediating the accumulation of parasites in the placenta. Here, we report in vitro assays to measure specific adhesion of infected erythrocytes to hyaluronic acid that is distinct from binding to chondroitin sulphate A, another glycosaminoglycan implicated as a receptor in placental malaria. In this study, specific adhesion of mature stage infected erythrocytes to hyaluronic acid of high purity immobilised on plastic surfaces was abolished by pre-treating hyaluronic acid with a specific hyaluronate lyase from Streptomyces, whereas the same treatment of chondroitin sulphate A had little effect. Adhesion to hyaluronic acid could not be explained by the presence of chondroitin sulphate A or other glycosaminoglycans in the hyaluronic acid preparations. Chinese hamster ovary cells bound in a similar manner in the assays and confirmed that hyaluronic acid was appropriately immobilised for cell adhesion. In contrast to parasites, these cells did not adhere to chondroitin sulphate A. The adsorption of hyaluronic acid onto plastic surfaces was also confirmed by the use of a specific hyaluronic acid-binding protein. Fixing cells with glutaraldehyde at the completion of adhesion assays reduced the number of parasites remaining adherent to hyaluronic acid, but not to chondroitin sulphate A or CD36. These findings have important implications for understanding and evaluating interactions between P. falciparum and hyaluronic acid that may be involved in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204224     DOI: 10.1016/s0020-7519(02)00097-8

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  9 in total

1.  Adhesion specificities of Plasmodium falciparum-infected erythrocytes involved in the pathogenesis of pregnancy-associated malaria.

Authors:  Lars Hviid
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

2.  Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite.

Authors:  Danielle I Stanisic; John Gerrard; James Fink; Paul M Griffin; Xue Q Liu; Lana Sundac; Silvana Sekuloski; Ingrid B Rodriguez; Jolien Pingnet; Yuedong Yang; Yaoqi Zhou; Katharine R Trenholme; Claire Y T Wang; Hazel Hackett; Jo-Anne A Chan; Christine Langer; Eric Hanssen; Stephen L Hoffman; James G Beeson; James S McCarthy; Michael F Good
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

3.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets.

Authors:  James G Beeson; Emily J Mann; Salenna R Elliott; Valentino M Lema; Eyob Tadesse; Malcolm E Molyneux; Graham V Brown; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2004-01-21       Impact factor: 5.226

4.  Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.

Authors:  Jo-Anne Chan; Katherine B Howell; Linda Reiling; Ricardo Ataide; Claire L Mackintosh; Freya J I Fowkes; Michaela Petter; Joanne M Chesson; Christine Langer; George M Warimwe; Michael F Duffy; Stephen J Rogerson; Peter C Bull; Alan F Cowman; Kevin Marsh; James G Beeson
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

5.  Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.

Authors:  Elizabeth G Kane; Andrew W Taylor-Robinson
Journal:  Malar Res Treat       Date:  2012-01-18

6.  Plasmodium vivax adherence to placental glycosaminoglycans.

Authors:  Kesinee Chotivanich; Rachanee Udomsangpetch; Rossarin Suwanarusk; Sasithon Pukrittayakamee; Polrat Wilairatana; James G Beeson; Nicholas P J Day; Nicholas J White
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

7.  Disruption of var2csa gene impairs placental malaria associated adhesion phenotype.

Authors:  Nicola K Viebig; Emily Levin; Sébastien Dechavanne; Stephen J Rogerson; Jürg Gysin; Joseph D Smith; Artur Scherf; Benoit Gamain
Journal:  PLoS One       Date:  2007-09-19       Impact factor: 3.240

Review 8.  Syncytiotrophoblast Functions and Fetal Growth Restriction during Placental Malaria: Updates and Implication for Future Interventions.

Authors:  Winifrida B Kidima
Journal:  Biomed Res Int       Date:  2015-10-26       Impact factor: 3.411

Review 9.  Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.

Authors:  Jo-Anne Chan; Freya J I Fowkes; James G Beeson
Journal:  Cell Mol Life Sci       Date:  2014-04-02       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.